CITIZEN CPR FOUNDATION BRINGS THE ENTIRE CHAIN OF SUDDEN CARDIAC ARREST SURVIVAL TO SEATTLE, WA
04 déc. 2019 14h42 HE
|
Citizen CPR Foundation
Overland Park, Kansas, Dec. 04, 2019 (GLOBE NEWSWIRE) -- The Citizen CPR Foundation will host the first Cardiac Arrest Survival Summit in Seattle, Washington December 10th through 13th at the Hyatt...
Biotricity Completes Development of its ECG Patch Platform
04 déc. 2019 08h00 HE
|
biotricity
REDWOOD CITY, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has completed...
CITIZEN CPR FOUNDATION BECOMES A CATALYST AND RESOURCE FOR ACTION TO IMPROVE CARDIAC ARREST SURVIVAL RATES
01 août 2019 11h42 HE
|
Citizen CPR Foundation
Overland Park, Kansas, Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Citizen CPR Foundation (CCPRF) today announced visionary new strategies designed to move the needle on sudden cardiac arrest (SCA)...
InCarda Therapeutics Appoints Daniel G. Welch as Executive Chairman of Board of Directors
03 avr. 2019 08h00 HE
|
InCarda Therapeutics, Inc.
SAN FRANCISCO, April 03, 2019 (GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for...
New Patent Issuances Strengthen InCarda Therapeutics’ Intellectual Property Portfolio Covering Novel Inhaled Cardiovascular Therapies
07 févr. 2019 08h05 HE
|
InCarda Therapeutics, Inc.
U.S. Patent Broadly Expands Coverage for Inhaled Treatment of Cardiovascular Disease to Include all Class I – IV Antiarrhythmic Drugs Additional U.S. Patent Provides Coverage for Combination of...
3Scan Selected for Crucial efforts in NIH SPARC Initiative
07 déc. 2018 10h04 HE
|
3Scan
San Francisco, Dec. 07, 2018 (GLOBE NEWSWIRE) -- 3Scan, Inc. (3Scan), the world’s leading 3D tissue imaging company has been contracted to provide crucial data in a multi-scale, multi-disciplinary...
BioSig Technologies to Present at the 8th Annual LD Micro Invitational
01 juin 2018 12h55 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, June 01, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Completes Private Placement
01 mai 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, May 01, 2018 (GLOBE NEWSWIRE) --
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed...
BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
28 mars 2018 02h00 HE
|
BioSig Technologies, Inc.
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA)...
BioSig Technologies to Open Operations Center in Austin, Texas
13 févr. 2018 08h00 HE
|
BioSig Technologies, Inc.
Santa Monica, CA, Feb. 13, 2018 (GLOBE NEWSWIRE) --
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform...